MANUEL GERVASIO DICKS: Open Payments
NPI 1184130916 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 30 payments from 9 companies in 2025. Trend: 2023 $342 · 2024 $1,099 · 2025 $1,198
Food & beverage: $1,198
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $544 |
| Braeburn Inc. | 9 | $254 |
| Teva Pharmaceuticals USA, Inc. | 4 | $195 |
| Indivior Inc. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| PROTEGA PHARMACEUTIALS INC | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
Products named: BRIXADI, UZEDY, Biktarvy, Epclusa, Yeztugo, SUBLOCADE, SPRAVATO, ROXYBOND.
Industry payments across FL — which companies pay providers there.
